| CABA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CABA shares outstanding history going back to 10/25/2019:
Also see: CABA Market Cap History CABA YTD Return |
CABA Shares Outstanding History — Cabaletta Bio Share Count Over Time
As of 5/7/2026 Cabaletta Bio has 163.05 million CABA shares outstanding. Investors often track the CABA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CABA share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 10/25/2019.
| CABA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CABA Historical Shares Outstanding: +42.44% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CABA Stock Price Chart |
| About Cabaletta Bio Inc |
| Cabaletta Bio, Inc. is a clinical-stage biotechnology company. Co. is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. We show 27 historical shares outstanding datapoints in our coverage of CABA's shares outstanding history. Understanding the changing numbers of CABA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CABA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CABA by allowing them to research CABA shares outstanding history as well as any other stock in our coverage universe. |
| CABA Current Stock Quote |
Quotes delayed 20 minutes  Free CABA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CABA Share Performance |
| Shares Outstanding Peers |
| Cabaletta Bio (CABA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CADL Shares Outstanding History CAH Shares Outstanding History CALA Shares Outstanding History CALC Shares Outstanding History CANO Shares Outstanding History CAPN Shares Outstanding History CAPR Shares Outstanding History CARA Shares Outstanding History CARM Shares Outstanding History CASI Shares Outstanding History More Healthcare companies » |
CABA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
